Evaluation and Treatment of Hypertriglyceridemia

Discuss Evaluation and Treatment of Hypertriglyceridemia at the Men's Health Forum; Berglund L, Brunzell JD, Goldberg AC, et al. Evaluation and Treatment of Hypertriglyceridemia: An Endocrine Society Clinical Practice Guideline. Journal ...

Go Back   MESO-Rx > Medicine > Men's Health Forum


Reply
 
LinkBack Thread Tools Display Modes
  #1  
Old 09-21-2012, 10:22 AM
Michael Scally MD's Avatar
Doctor of Medicine
 
Join Date: Mar 2006
Location: Texas; Italy
Posts: 12,389
Default Evaluation and Treatment of Hypertriglyceridemia

Berglund L, Brunzell JD, Goldberg AC, et al. Evaluation and Treatment of Hypertriglyceridemia: An Endocrine Society Clinical Practice Guideline. Journal of Clinical Endocrinology & Metabolism 2012;97(9):2969-89. Sign In / http://www.endo-society.org/guidelin...mia_FinalA.PDF

Objective: The aim was to develop clinical practice guidelines on hypertriglyceridemia.

Participants: The Task Force included a chair selected by The Endocrine Society Clinical Guidelines Subcommittee (CGS), five additional experts in the field, and a methodologist. The authors received no corporate funding or remuneration.

Consensus Process: Consensus was guided by systematic reviews of evidence, e-mail discussion, conference calls, and one in-person meeting. The guidelines were reviewed and approved sequentially by The Endocrine Society's CGS and Clinical Affairs Core Committee, members responding to a web posting, and The Endocrine Society Council. At each stage, the Task Force incorporated changes in response to written comments.

Conclusions: The Task Force recommends that the diagnosis of hypertriglyceridemia be based on fasting levels, that mild and moderate hypertriglyceridemia (triglycerides of 150–999 mg/dl) be diagnosed to aid in the evaluation of cardiovascular risk, and that severe and very severe hypertriglyceridemia (triglycerides of > 1000 mg/dl) be considered a risk for pancreatitis. The Task Force also recommends that patients with hypertriglyceridemia be evaluated for secondary causes of hyperlipidemia and that subjects with primary hypertriglyceridemia be evaluated for family history of dyslipidemia and cardiovascular disease. The Task Force recommends that the treatment goal in patients with moderate hypertriglyceridemia be a non-high-density lipoprotein cholesterol level in agreement with National Cholesterol Education Program Adult Treatment Panel guidelines. The initial treatment should be lifestyle therapy; a combination of diet modification and drug therapy may also be considered. In patients with severe or very severe hypertriglyceridemia, a fibrate should be used as a first-line agent.
__________________
HPTA Restoration (PCT/AIH) & AAS Cycles Consultations Available.

Email for free copy (pdf), "Anabolic Steroids - A Question of Muscle: Human Subject Abuses in Anabolic Steroid Research."

Email - [email protected]
Twitter - https://twitter.com/#!/michaelscally
Blog - http://michaelscally.blogspot.com/
FaceBook - https://www.facebook.com/profile.php?id=100000559797692
Post Cycle Therapy (PCT)/ Androgen Induced Hypogonadism (AIH) - https://www.facebook.com/groups/609337655745437/
Reply With Quote
Reply

Thread Tools
Display Modes

Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

BB code is On
Smilies are On
[IMG] code is On
HTML code is Off
Trackbacks are On
Pingbacks are On
Refbacks are On



All times are GMT -4. The time now is 11:39 AM.



Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2014, vBulletin Solutions, Inc.